Login
$BIAF
$1.98 -$0.02 (1.0%) After hours

Ownership

13F as of Q2 2026 · 896.3K shares outstanding

Who owns BIAF?

By type of holder
Institutions 86.9% Insiders 13.1% Everyone else 0.0%
Concentration Top 10 holders own 227.0%
Joyce Roby 72.5% · Sabby Management, LLC 40.8%
Institutional ownership
86.9%
+59.9 pts vs last qtr
Institutional holders
20
+5 vs last qtr
Net shares bought
+536.8K
by institutions in Q2 2026
New / sold out
9 / 4
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Sabby Management, LLC NEW +365.6K
  • BlackRock, Inc. NEW +98.8K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Schonfeld Strategic Advisors LLC SOLD OUT −24.4K
  • UBS Group AG −5.0K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for bioAffinity Technologies, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025
−61.7%
−27.41% a year
Each share's claim on the business
+161.4%
grew without buying or selling a share
Spent on buybacks vs paid in stock
— vs $2.66M
over 4 fiscal years
Diluted shares, split-adjusted
392.0K4.6M8.8M2022: 4.5M shares'222023: 8.7M shares'232024: 404.2K shares'242025: 1.7M shares'25
Buybacks Stock-based comp
$0$494.8K$989.7K2022 buybacks: $02022 stock comp: $248.6K'222023 buybacks: $02023 stock comp: $748.8K'232024 buybacks: $02024 stock comp: $989.7K'242025 buybacks: $02025 stock comp: $671.5K'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years1% 1–3 years0% Under 1 year99%
Quarterly turnover
123.3%
of institutional shares changed hands
Top 10 managers, median time held
1 quarter

Super Investors

Investment managers reporting BIAF on Form 13F
SM
Sabby Management, LLC
Shares
365.6K
% of company
40.80%
Change vs last qtr
NEW
Held since
Q2 '26
B
BlackRock, Inc.
Shares
98.8K
% of company
11.02%
Change vs last qtr
NEW
Held since
Q2 '26

22 more super investors behind a free account

See every manager holding bioAffinity Technologies, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting BIAF on Form N-PORT; together they hold 13.6% of the company
FE
Fidelity Concord Street Trust
Position value
$46.9K
% of company
3.13%
% of the fund
0.00%
As of
May 31, 2026
VE
Position value
$45.1K
% of company
6.20%
% of the fund
0.00%
As of
June 30, 2026

6 more funds behind a free account

See every fund holding bioAffinity Technologies, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
JR
Joyce Roby
Insider
Shares
649.7K
% of company
72.49%
Change vs last qtr
—
Held since
—
ZM
Zannes Maria
Insider
Shares
280.4K
% of company
31.28%
Change vs last qtr
—
Held since
—

10 more holders behind a free account

See every insider and 5%+ holder of bioAffinity Technologies, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support